Protocol Ledger

NCT04031677 · Phase III · RECRUITING

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Interventional Phase III clinical trial protocol NCT04031677 sponsored by European Organisation for Research and Treatment of Cancer - EORTC in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-01-20 Enrollment: 250 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04031677
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)250 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04031677
Protocol FieldVerified Registry Value
NCT IdentifierNCT04031677
Consolidated Lead SponsorEuropean Organisation for Research and Treatment of Cancer - EORTC
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment250 participants (ESTIMATED)
Registered Start Date2021-01-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI